Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection.
Zambrano LD, Ly KN, Link-Gelles R, Newhams MM, Akande M, Wu MJ, Feldstein LR, Tarquinio KM, Sahni LC, Riggs BJ, Singh AR, Fitzgerald JC, Schuster JE, Giuliano JS Jr, Englund JA, Hume JR, Hall MW, Osborne CM, Doymaz S, Rowan CM, Babbitt CJ, Clouser KN, Horwitz SM, Chou J, Patel MM, Hobbs C, Randolph AG, Campbell AP; Overcoming COVID-19 Investigators. Zambrano LD, et al. Pediatr Infect Dis J. 2022 Nov 1;41(11):891-898. doi: 10.1097/INF.0000000000003689. Epub 2022 Sep 7. Pediatr Infect Dis J. 2022. PMID: 36102740 Free PMC article.
A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB. Roper LE, et al. Among authors: link gelles r. Vaccine. 2025 Jan 2;45:126633. doi: 10.1016/j.vaccine.2024.126633. Online ahead of print. Vaccine. 2025. PMID: 39755055
Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States.
Tenforde MW, Reeves EL, Weber ZA, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Yang DH, Grannis SJ, Irving SA, Ong TC, Link-Gelles R, Salas SB, Sy LS, Lewin B, Contreras R, Zerbo O, Fireman B, Hansen J, Timbol J, Sheffield T, Bride D, Arndorfer J, VanOtterloo J, McEvoy CE, Akinsete OO, Essien IJ, Dixon BE, Rogerson C, Fadel WF, Duszynski T, Naleway AL, Barron MA, Rao S, Mayer D, Chavez C, Ball SW, Payne AB, Ray C, Dickerson M, Neelam V, Adams K, Flannery B, DeCuir J, Garg S. Tenforde MW, et al. Among authors: link gelles r. Clin Infect Dis. 2024 Dec 4:ciae597. doi: 10.1093/cid/ciae597. Online ahead of print. Clin Infect Dis. 2024. PMID: 39656838
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024.
Lefferts B, Bressler S, Keck JW, Desnoyers C, Hodges E, January G, Morris K, Herrmann L, Singleton R, Aho S, Rogers J, Newell K, Ohlsen E, Link-Gelles R, Dawood FS, Bruden D, Fischer M, Klejka J, Scobie HM. Lefferts B, et al. Among authors: link gelles r. MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1015-1021. doi: 10.15585/mmwr.mm7345a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541241 Free PMC article.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023.
Ciesla AA, Mak J, Roper LE, Fleming-Dutra KE, Smith ZR, Wiegand RE, Britton A, Miller J, Link-Gelles R. Ciesla AA, et al. Among authors: link gelles r. Influenza Other Respir Viruses. 2024 Nov;18(11):e70038. doi: 10.1111/irv.70038. Influenza Other Respir Viruses. 2024. PMID: 39522959 Free PMC article.
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: link gelles r. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. Lancet. 2024. PMID: 39426837
122 results